Question 1

What are the differences between orlistat and polyglucosamine in terms of effectiveness?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity clinical trial (NCT02529631). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my current health conditions affect my eligibility for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity clinical trial (NCT02529631). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of for both treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity clinical trial (NCT02529631). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my diet need to change if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity clinical trial (NCT02529631). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring or follow-up will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity clinical trial (NCT02529631). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with taking either of these treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity clinical trial (NCT02529631). Contact the study team or your healthcare provider for specific answers.

What this study is about